Detalhe da pesquisa
1.
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial.
Lancet
; 393(10191): 2591-2598, 2019 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31178155
2.
Early onset breast cancer: differences in risk factors, tumor phenotype, and genotype between North African and South European women.
Breast Cancer Res Treat
; 166(2): 631-639, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28779219
3.
Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomas.
Histopathology
; 70(7): 1089-1097, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28106924
4.
A new model for cancer research in France.
Nat Rev Cancer
; 6(8): 645-51, 2006 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-16862194
5.
Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy.
Kidney Int
; 85(2): 457-70, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24067439
6.
Hereditary-like urothelial carcinomas of the upper urinary tract benefit more from adjuvant cisplatin-based chemotherapy after radical nephroureterectomy than do sporadic tumours.
BJU Int
; 113(4): 574-80, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23937547
7.
6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial.
Lancet Oncol
; 14(8): 741-8, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23764181
8.
Innovative cancer therapies: putting costs into context.
Cancer
; 118(9): 2367-71, 2012 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21918962
9.
Delivering affordable cancer care in high-income countries.
Lancet Oncol
; 12(10): 933-80, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21958503
10.
Pulmonary toxicity related to systemic treatment of nonsmall cell lung cancer.
Cancer
; 117(14): 3069-80, 2011 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21283982
11.
Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study.
Cancer
; 117(24): 5500-8, 2011 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21638278
12.
Bevacizumab treatment for advanced breast cancer.
Oncologist
; 16(12): 1684-97, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21976315
13.
Comprehensive integrative profiling of upper tract urothelial carcinomas.
Genome Biol
; 22(1): 7, 2021 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33397444
14.
Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic drivers.
Sci Rep
; 10(1): 701, 2020 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31959902
15.
Temsirolimus-induced glomerulopathy.
Oncology
; 76(3): 170-2, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19212144
16.
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours.
Eur J Cancer
; 120: 132-139, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31522033
17.
Potential predictive markers of response to EGFR-targeted therapies in colorectal cancer.
Crit Rev Oncol Hematol
; 66(1): 21-30, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18206383
18.
Long-Term Survival in Gastroesophageal Junction Adenocarcinoma: Ramucirumab.
Case Rep Gastroenterol
; 12(2): 532-539, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30283289
19.
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny.
Cell Rep
; 25(3): 811-821.e5, 2018 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30332658
20.
Novel therapeutic strategies combining antihormonal and biological targeted therapies in breast cancer: focus on clinical trials and perspectives.
Crit Rev Oncol Hematol
; 64(2): 115-28, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17702596